Laboratorios Farmaceuticos ROVI (ROVI) — Defensive Interval Ratio
Laboratorios Farmaceuticos ROVI (ROVI) has a Defensive Interval Ratio of 377 days as of September 2025. Defensive assets of €191.39 Million (cash €-, short-term investments €-, receivables €191.39 Million) cover 377 days of daily cash needs of €508.00K/day. See ROVI net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Laboratorios Farmaceuticos ROVI Defensive Interval Ratio (2003–2024)
This chart shows how Laboratorios Farmaceuticos ROVI's Defensive Interval Ratio has evolved across 22 annual periods from 2003 to 2024. As of September 2025, the ratio stands at 377 days, meaning defensive assets of €191.39 Million can fund 377 days of operations without new revenue. See how leveraged is Laboratorios Farmaceuticos ROVI's balance sheet to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Laboratorios Farmaceuticos ROVI (2003–2024)
The table below presents the year-by-year Defensive Interval Ratio for Laboratorios Farmaceuticos ROVI from 2003 to 2024, covering 22 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Laboratorios Farmaceuticos ROVI market cap and net worth.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 302 days | €129.73 Million | €429.18K/day | €- | €227.00K | ▲ +41 days |
| 2023 | 262 days | €143.25 Million | €547.52K/day | €- | €-65.00K | ▼ -22 days |
| 2022 | 284 days | €228.52 Million | €805.17K/day | €44.42 Million | €-65.00K | ▼ -23 days |
| 2021 | 307 days | €160.00 Million | €521.61K/day | €- | €-65.00K | ▲ +57 days |
| 2020 | 250 days | €84.14 Million | €336.68K/day | €- | €-65.00K | ▼ -63 days |
| 2019 | 313 days | €91.58 Million | €292.35K/day | €- | €-65.00K | ▲ +63 days |
| 2018 | 251 days | €60.12 Million | €239.76K/day | €- | €-65.00K | ▲ +46 days |
| 2017 | 205 days | €41.05 Million | €200.61K/day | €- | €-65.00K | ▼ -12 days |
| 2016 | 217 days | €45.36 Million | €209.43K/day | €- | €32.00K | ▼ -68 days |
| 2015 | 285 days | €46.21 Million | €162.26K/day | €- | €61.00K | ▼ -30 days |
| 2014 | 315 days | €53.59 Million | €170.18K/day | €- | €1.22 Million | ▼ -56 days |
| 2013 | 371 days | €59.34 Million | €159.84K/day | €- | €1.22 Million | ▼ -22 days |
| 2012 | 393 days | €59.35 Million | €151.05K/day | €- | €1.12 Million | ▼ -111 days |
| 2011 | 504 days | €78.38 Million | €155.50K/day | €- | €6.00 Million | ▼ -115 days |
| 2010 | 619 days | €87.55 Million | €141.44K/day | €- | €26.08 Million | ▲ +589 days |
| 2009 | 29 days | €5.15 Million | €174.66K/day | €- | €2.00K | ▼ -377 days |
| 2008 | 406 days | €52.39 Million | €128.93K/day | €- | €72.00K | ▼ -69 days |
| 2007 | 475 days | €44.97 Million | €94.58K/day | €- | €2.78 Million | ▲ +133 days |
| 2006 | 343 days | €34.63 Million | €101.09K/day | €- | €275.00K | ▲ +333 days |
| 2005 | 10 days | €89.32 Billion | €9.18 Billion/day | €- | €3.11 Million | ▼ -3 days |
| 2004 | 13 days | €130.67 Million | €9.95 Million/day | €- | €12.72 Million | ▼ -301 days |
| 2003 | 314 days | €20.74 Million | €66.10K/day | €- | €- | — |